Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
IGM Biosciences, Inc.
Scientific Title
A Phase 1 Open-label, Multicenter Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of IGM-2323 in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma